2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 02:17, 26 December 2023
, 26 December 2023→Clinical Trials
(→Todo) |
|||
| Line 530: | Line 530: | ||
|- | |- | ||
|{{pmid_text|35182418}} | |{{pmid_text|35182418}} | ||
* [https://www.nmn.com/news/nmn-tablet-blood-nad-levels-humans NMN.com article] | |||
|[[RCT]], 2 weeks | |[[RCT]], 2 weeks | ||
*1000 mg MIB-626 | *1000 mg MIB-626 | ||